Renal Business Today - dialysis, end-stage renal disease (ESRD), home dialysis, chronic kidney disease (CKD), nephrology, Medicare bundle, kidney, dialysis practice management, kidney disease patients

FEATURES

Essay Contest for Kidney Patients

GLENDALE, Calif.—The Renal Support Network (RSN), a nonprofit, patient-focused, patient-run organization that provides nonmedical services to those affected by chronic kidney disease (CKD), encourages people with kidney ...read more

Travel on Dialysis

“The world is a book, and those who do not travel read only one page,” said Augustine of Hippo. For many, travel provides an expanded world view and a great deal of joy. For many hemodialysis patients, travel seems ...read more

2013 RPA Meeting

If you missed the three-day, 2013 Renal Physician Association conference held in New Orleans, Renal Business Today was there and has the highlights available at your fingertips in the latest digital issue. Renal ...read more

Venous Needle Dislodgement

Venous needle dislodgement (VND) occurs when a venous needle dislodges from a patient's vascular access during hemodialysis treatment. This report discusses VND severity and presents best practices and other solutions to ...read more

A Recipe Guide to Lowering Salt Intake

Whether you are a kidney disease patient or a non-kidney patient, it is important to keep your kidneys as healthy as possible by following a low-sodium diet. Did you know that for a healthy individual over the age of 50, a ...read more

Latest Headlines

The Next Challenger to the EPO Monopoly

Editor's Note: The online version of this interview includes corrections from the print version due to transcription innacuracies.At the 45th ERA-EDTA Congress in Stockholm, Palo-Alto, Calif.-basedAffymax presented preliminary data showing its anemia drug Hematide was well ...More
July 31, 2008
Posted in Articles, Business, Clinical & Pharma
Preventive Foot Care in Hemodialysis Patients

Comprehensive care of hemodialysis patients poses a significant challenge for nephrologists. Although protocol driven approaches by hemodialysis centers have significantly improved standardized care, significant gaps remain in overall medical care provided to hemodialysis ...More
July 31, 2008
Posted in Articles, Clinical & Pharma
A Short History of Vascular Access Care

Gerald Beathard, MD, PhD, is a guru is the purest sense of the word. At one time, he had trained everyone doing interventional nephrology, or had trained the person an interventional nephrologist had trained with. Of course, that’s no longer true as interventional ...More
July 31, 2008
Posted in Articles, Clinical & Pharma
Fluid management in dialysis

HEALTHY KIDNEYS maintain electrolyte and acid-base balance and remove metabolic waste and excess fluids from the body. As kidney function deteriorates, metabolic wastes and fluid continue to accumulate in the blood leading to complications such as hypertension, anemia, ...More
July 31, 2008
Posted in Articles
Web site educates public about lab tests

HAS A PATIENT ever wondered what happens to his or her blood when it gets sent to the lab for analysis? Do visions of robed alchemists toiling over a heated cauldron come to mind? Hopefully not, but there is a Web site that aims to simplify how and why most lab tests are ...More
July 31, 2008
Posted in Articles
Simple lab test for bone disease linked to risk of death in dialysis patients

WASHINGTON--Among patients receiving dialysis for chronic kidney disease, high levels of alkaline phosphatase—a routinely measured laboratory marker of bone disease—could signal an increased risk of death, according to a study in the November Journal of the American Society ...More
July 31, 2008
Posted in News, Clinical & Pharma
Pay-for-performance has little impact on quality care, study says

An analysis in the July/August issue of Health Affairs studied pay-for-performance programs among Massachusetts physician groups and found the programs have little or no impact on quality of care. (Read story here)SOURCE: American Medical News ...More
July 31, 2008
Posted in Articles, Practice Management
FDA tells Amgen, Johnson & Johnson to change ESA label for cancer

The U.S. Food and Drug Administration has told Amgen and Johnson & Johnson they must revise the labels of its anemia drugs to say that the drugs shouldn’t be used in cancer patients undergoing chemotherapy when a cure is anticipated for their cancer. (Read story ...More
July 31, 2008
Posted in Articles, Business, Clinical & Pharma, Government & Regulation
Fresenius gets $2.4 billion loan to buy APP

Fresenius SE has secured a $2.4 billion loan to buy Schaumburg, Ill.-based APP Pharmaceuticals, which is largest U.S. supplier of the blood-thinning drug heparin. In early July, Fresenius agreed to acquire APP for $3.7 billion. (Read story here)SOURCE: Reuters (U.K.) ...More
July 31, 2008
Posted in Articles, Business, Clinical & Pharma
Court rules in favor of C.R. Bard in graft patent infringement suit

MURRAY HILL, N.J.—A U.S. District Court in Arizona ruled that W.L. Gore & Associates failed to prove that C.R. Bard’s patents were unenforceable due to inequitable conduct, according to Bard. ...More
July 31, 2008
Posted in News, Business